Marseille-Kliniken AG

EANS-Adhoc: - Marseille-Kliniken Group completes disposing of its rehabilitation division

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Disposing of rehabilitation division completed

30.04.2010

Berlin, 30 April 2010. Marseille-Kliniken Group (Prime Standard, ISIN DE 0007783003, MKA) has completed the announced sale of its rehabilitation division.

The transaction includes the rehabilitation clinics operated by Karlsruher Sanatorium AG, a subsidiary of Marseille-Kliniken AG as well as rehabilitation clinic companies, directly held by Marseille-Kliniken AG. The buyer is a joint venture between the funds consulted by financial investor AUCTUS Capital Partners AG and the existing management team of the clinics.

End of ad hoc release

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.hillermann-consulting.de

Marseille-Kliniken AG
Dr. Ute Buchheim
Friedrich-Ebert-Str. 65
33330 Gütersloh
Germany
Tel.: +49-(0)5241 / 90 39-35
Fax: +49-(0)5241 / 90 39-39
www.marseille-kliniken.com

Branche: Pharmaceuticals
ISIN:      DE0007783003
WKN:        778300
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              Hamburg / regulated dealing



Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: